Emma's current research focuses on the profiling of the genomic regulatory landscape of discrete cell populations derived from post-mortem brain samples. This work holds significant potential in providing valuable understanding of both neurodegeneration and neuropsychiatric disorders at the cellular level. Based on this research they are developing blood-based biomarkers for neurodegenerative disorders including Alzheimer’s Disease and Motor Neuron Disease. Another aspect of Emma's work involves developing new methods such as epigenomic tools based on the CRISPR-cas9 system to understand the role epigenetics play in brain disorders such as Alzheimer’s disease.
Research projects that Emma has been involved in
Neurodegeneration
Improving early diagnosis of neurodegenerative disease
Improving DNA testing for neurodegenerative diseases
News involving Emma
We use cookies to give you the best experience of our website. By browsing you agree to our use of cookies.